Doctor profile · Federal record
Dr. SOUBHI BAHNA, M.D.
Endocrinology, Diabetes & Metabolism Physician (CMS: ENDOCRINOLOGY) · Internal Medicine Physician · Hospitalist Physician · TORRANCE, CA
- NPI 1497069751
- Accepts Medicare
- 17 yrs in practice
- Licensed in 3 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2841 LOMITA BLVD STE 320
TORRANCE, CA 905055116
(310) 257-7298
fax (310) 598-3119
Credentials & registration
- NPI registered
- July 2010 — 16 yrs on file
- Profile last updated
- February 7, 2023
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State licenses (3)
- California #C169946 · Florida #ME146411 · Missouri #2013018546
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1497069751. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,008
Distinct HCPCS
8
Medicare allowed
$53,381
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 660 | 11 | $24 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 128 | 128 | $180 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 68 | 53 | $139 | |
82962 |
Blood glucose (sugar) test performed by hand-held instrument | 67 | 46 | $3 | |
83036 |
Hemoglobin a1c level | 32 | 28 | $10 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 22 | 22 | $121 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 19 | 18 | $98 | |
96372 |
Injection of drug or substance under skin or into muscle | 12 | 12 | $16 |
In context: peer comparison
Among 9 peers in this city , average services per provider: 425. This provider delivers 2.4× the peer median.Open Payments
Industry payments received
All-time total
$1,691
Transactions
85
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbott Laboratories | 24 | $446.82 | |
| Lilly USA, LLC | 16 | $321.25 | |
| Amgen Inc. | 6 | $235.68 | |
| Tandem Diabetes Care, Inc. | 7 | $231.22 | |
| Novo Nordisk Inc | 13 | $195.53 | |
| Dexcom, Inc. | 16 | $186.85 | |
| Xeris Pharmaceuticals, Inc. | 2 | $45.59 | |
| LivaNova USA, Inc. | 1 | $28.52 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
330
Patients
109
Total drug cost
$128,562
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 66 | 29 | $1,292 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 60 | 23 | $847 |
| Jardiance (Empagliflozin) | Brand | 56 | 24 | $49,726 |
| Ozempic (Semaglutide) | Brand | 38 | 20 | $43,272 |
| Glipizide Er (Glipizide) | Brand | 22 | 13 | $314 |
| Novolog Flexpen (Insulin Aspart) | Brand | 15 | 0 | $9,124 |
| Atorvastatin Calcium | Generic | 14 | 0 | $250 |
| Basaglar Kwikpen U-100 (Insulin Glargine,hum.Rec.Anlog) | Brand | 14 | 0 | $4,948 |
| Nano 2nd Gen Pen Needle (Pen Needle, Diabetic) | Brand | 12 | 0 | $1,472 |
| Alendronate Sodium | Generic | 11 | 0 | $194 |